Pumice Aggregate

SECTION 2: Hazards identification

NFPA Rating GHS Classification This product may contain trace amounts of crystalline silica Crystalline silica dust is classified as Hazardous. Dust in/on the product or generated by crushing or abrasion may form crystalline silica of respirable size that is small enough to be inhaled into the lungs

Precautionary statements

•P102: Keep out of reach of children •P103: Read label before use

Hazard statements

•P202 Do not handle until all safety precautions have been read and ·H333 May be harmful if inhaled understood ·H303 May be harmful if swallowed •P281 Use personal protective equipment as required ·H315 Causes skin irritation •P501: Dispose of contents and container in accordance with all local, ·H320 Causes eye irritation regional, national and international regulations ·H350 May cause cancer •P264: Wash thoroughly after handling •P270: Do not eat, drink, or smoke when using this product •P272: Contaminated work clothing should not be allowed out of the workplace •P260: Do not breathe dust/fume/gas/mist/vapors/spray •P271: Only use outdoors or in a well ventilated area •P285: In case of inadequate ventilation wear respiratory protection HMIS-RATINGS (SCALE 0 – 4) HEALTH 1 Health = 1 0

NFPA Ratings

FLAMMABILITY 0 Fire = 0 1 0 Reactivity = 0 REACTIVITY 0 EMERGENCY OVERVIEW: For Routine Industrial Applications SYMPTOMS OF OVER-EXPOSURE BY ROUTE OF EXPOSURE: The most significant route of occupational overexposure is contact with skin. The symptoms of overexposure to this product are as follows: INHALATION: It is possible to breathe this material under certain conditions of handling and use (for example, during mixing or spraying in a confined area). Breathing small amounts of this material during normal handling is not likely to cause harmful effects. Breathing large amounts may be harmful. CONTACT WITH SKIN or EYES: Contact with the eyes may cause slight transient (temporary) eye irritation. Corneal injury is unlikely. Prolonged or repeated skin contact may dry the skin. Symptoms may include redness, drying and cracking of skin. Additional symptoms of skin contact may include: allergic skin reaction (delayed skin rash which may be followed by blistering, scaling and other skin effects), and numbness. INGESTION: Ingestion is not anticipated to be a significant route of over-exposure to this product. INJECTION: Though injection is not anticipated to be a significant route of over-exposure to this product, if it occurs, local reddening, tissue swelling, and discomfort may result. HEALTH EFFECTS OR RISKS FROM EXPOSURE: An Explanation in Lay Terms. ACUTE: Contact with this solution may cause irritation of the eyes, skin, mucous membranes, and any other exposed tissue. If inhaled, irritation of the respiratory system may occur, with coughing, and breathing difficulty. CHRONIC: Repeated skin contact with this product may result in dermatitis (inflammation and reddening of the skin).

2.1 Classification of the substance or mixture

•This product may contain trace amounts of crystalline silica. Crystalline silica dust is classified as Hazardous. Dust in/on the product or generated by crushing or abrasion may form crystalline silica of respirable size that is small enough to be inhaled into the lungs.